Cerebrovascular Disease

  • Karen L. Furie
  • Christopher S. Ogilvy
  • Martin Smrčka
  • Nijasri C. Suwanwela
  • Ufuk Can
  • Hakan Ay
  • Steven C. Cramer
  • Steven M. Greenberg
  • Guy Rordorf
  • Seth P. Finklestein
  • Gary P. Foster
  • Walter J. Koroshetz
  • Nitaya Suwanwela
  • J. Philip Kistler


Cerebrovascular disease, the third leading cause of death after heart disease and cancer in developed countries, has an overall prevalence of 794 per 100,000. In the United States, more than 400,000 patients are discharged each year from hospitals after stroke. The loss of these patients from the work force and the extended hospitalization they require during recovery make the economic impact of the disease one of the most devastating in medicine.


Internal Carotid Artery Basilar Artery Giant Cell Arteritis Cerebral Amyloid Angiopathy Embolic Stroke 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kistler JP: Cerebrovascular Disease. In Atherosclerosis and Coronary Artery Disease. Edited by Fuster V, Ross R, Topol EJ. Philadelphia: Lippincott-Raven; 1996: 463–474.Google Scholar
  2. 2.
    Kistler JP, Ropper AH, Martin JB: Cerebrovascular Diseases. In Harrison’s Principles of Internal Medicine, edn 13. Edited by Isselbacher KJ, Braunwald E, Wilson JD, et al.:. New York: McGraw-Hill; 1994: 2233–2256.Google Scholar
  3. 3.
    Sacco RL, Ellenberg JH, Mohr JP, et al.: Infarcts of undetermined cause: The NINCDS stroke data bank. Ann Neurol 1989, 25:382–390.Google Scholar
  4. 4.
    Fisher CM, Gore I, Okabe M, et al.: Atherosclerosis of the carotid and vertebral arteries: Extracranial and intracranial. J Neuropathol Exp Neural 1965, 24:455–476.Google Scholar
  5. 5.
    Adams RD, Sidman RL: Cerebrovascular Diseases. In Introduction to Neuropathology. New York McGraw-Hill; 1968: 197.Google Scholar
  6. 6.
    Kistler JP, Buonanno FS, Gress DR: Carotid endartectomy—specific therapy based on pathophysiology. Nengl J Med 1991; 325: 505–507.CrossRefGoogle Scholar
  7. 7.
    Kistler JP, Furie KL: Carotid endarterectomy revisited. N Engl J Med 2000, 342: 1743–1745.PubMedCrossRefGoogle Scholar
  8. 8.
    Wechsler LR, Kistler JP, Davis KR, et al.: The prognosis of carotid siphon steno- 33. sis. Stroke 1986, 17:714–718.Google Scholar
  9. 9.
    Caplan LR, Babikian C, Helgason C, et al.: Occlusive disease of the middle cerebral artery. Neurology 1985, 35:975–982.Google Scholar
  10. 10.
    Fisher CM, Karnes WE, Kubik CS: Lateral medullary infarction: the pattern of vascular occlusion. Neuropathol Exp Neurol 1961, 20: 323–379.CrossRefGoogle Scholar
  11. 11.
    Kubik CS, Adams RD: Occlusion of the basilar artery: a clinical and pathological study. Brain 1946, 69: 73–121.PubMedCrossRefGoogle Scholar
  12. 12.
    Watanabe T, Sato K, Yoshimoto T: Basilar artery occlusion caused by thrombosis of atherosclerotic fusiform aneurysm of the basilar artery. Stroke 1994, 25 (5): 1068–1070.PubMedCrossRefGoogle Scholar
  13. 13.
    Levine RL, Turski PA, Grist TM: Basilar artery dolichoectasia: review of the literature and six patients studied with magnetic resonance angiography. J Neuroimaging 1995, 5 (3): 164–170.PubMedGoogle Scholar
  14. 14.
    Besson G, Bogousslaysky J, Moulin T, et al.: Vertebrobasilar infarcts in patients with dolichoectatic basilar artery. Acta Neurol Scand 1995, 91(1):37–42.Google Scholar
  15. 15.
    Kistler JP, Ojemann RG, Crowell RM: Atherothrombotic Disease of the Carotid Circulation: Pathophysiology, Evaluation and Management. In Surgical Management of Neurovascular Disease, edn 3. Edited by Ojemann RG, Ogilvy CS, Crowell RM, et al.:. Baltimore: Williams & Willcins; 1995: 3–24.Google Scholar
  16. 16.
    Suwanwela N, Can U, Furie K, et al.: Carotid Doppler ultrasound criteria for internal carotid artery stenosis based on residual lumen diameter calculated from en block carotid endarterectomy specimens. Stroke 1996, 27:1965–1969.Google Scholar
  17. 17.
    Can U, Furie KL, Suwanwela N, et al.: Transcranial Doppler ultrasound criteria for hemodynamically significant carotid artery stenosis based on residual lumen diameter calculated from en bloc endarterectomy specimens. Stroke (in press).Google Scholar
  18. 18.
    Furie KL, Suwanwela N, Can U, et al.: Magnetic resonance angiography criteria for predicting hemodynamically significant carotid artery stenosis. Work in progress.Google Scholar
  19. 19.
    Couderc R, Mahieux F, Bailleul S, et al.: Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke 1993, 24:661–664.Google Scholar
  20. 20.
    North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991, 325: 445–453.Google Scholar
  21. 21.
    Barnett HJ, Taylor DW, Eliasziw M, et al.: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998, 339:1415–1425.Google Scholar
  22. 22.
    European Carotid SurgeryTrialists’ Collaborative Group. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (7099%) or with mild (0–29%) carotid stenosis. Lancet 1991, 337: 1235–1243.Google Scholar
  23. 23.
    Mayberg MR, Wilson SE, Yatsu F, et al.: Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 1991, 266:3289–3294.Google Scholar
  24. 24.
    Kistler JP, Buonanno FS, Gress DR: Carotid endarterectomy: specific therapy based on pathophysiology. N Engl J Med 1991, 325: 505–507.PubMedCrossRefGoogle Scholar
  25. 25.
    Hobson RW II, Weiss DG, Fields WS, et al.: Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993, 328:221–227.Google Scholar
  26. 26.
    Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for symptomatic carotid stenosis. JAMA 1995, 273: 1421–1428.Google Scholar
  27. 27.
    Eagle KA, Coley CM, Newell JB, et al.: Combining clinical and thallium data. optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989, 110:859–866.Google Scholar
  28. 28.
    Beebe HG, Archie JP, Baker WH, et al.: Concern about safety of carotid angioplasty. Stroke 1996, 27:197–198.Google Scholar
  29. 29.
    The Warfarin-Aspirin Recurrent Stroke Study (WARSS), The Antiphospholipid Antibodies and Stroke Study (APASS), The Patent Foramen Ovale in Cryptogenic Stroke Study (PICSS), The Hemostatic System Activation Study (HAS), The Genes in Stroke Study (GENESIS): The feasibility of a collaborative double-blind study using an anticoagulant. Cerebrovasc Dis 1997, 7: 100–112.Google Scholar
  30. 30.
    The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N Engl J Med 1985, 313: 1191–1200.CrossRefGoogle Scholar
  31. 31.
    Mohr JP, Kase CS, Wolf PA: Lacunes in the NINCDS pilot stroke data bank [Abstract]. Ann Neurol 1982, 12: 84.Google Scholar
  32. 32.
    Fisher CM: Lacunar stroke and infarcts: a review. Neurology 1982, 32: 871–876.PubMedCrossRefGoogle Scholar
  33. 33.
    Fisher CM: Capsular infarcts; the underlying vascular lesion. Arch Neural 1979, 36: 65–73.CrossRefGoogle Scholar
  34. 34.
    Mohr JP: Lacunes. Stroke 1982, 13: 3–11.PubMedCrossRefGoogle Scholar
  35. 35.
    Fisher CM: Lacunar infarcts: a review. Cerebrovasc Dis 1991, 1: 311–320.CrossRefGoogle Scholar
  36. 36.
    Fisher CM: The arterial lesions underlying lacunes. Acta Neuropathol 1969, 12: 1–15.CrossRefGoogle Scholar
  37. 37.
    Fisher CM, Caplan LR: Basilar artery branch occlusion: a cause of pontine infarction. Neurology 1971, 21: 900–903.PubMedCrossRefGoogle Scholar
  38. 38.
    Pullicino PM: Pathogenesis of Lacunar Infarcts and Small Deep Infarcts. In Advances in Neurology. Edited by Pullicino PM, Caplan LR, Hommel M. New York Raven Press; 1991: 125–139.Google Scholar
  39. 39.
    Fisher CM: Thalamic pure sensory stroke: a pathological study. Neurology 1978, 28: 1141–1144.PubMedCrossRefGoogle Scholar
  40. 40.
    Fisher CM, Caplan LR: Basilar artery branch occlusion: a cause of pontine infarction. Neurology 1971, 21: 900–905.PubMedCrossRefGoogle Scholar
  41. 41.
    Fisher CM: Bilateral occlusion of basilar artery branches. J Neurol Neurosurg Psychiatry 1977, 40: 1182–1189.PubMedCrossRefGoogle Scholar
  42. 42.
    Fisher CM: Pure sensory stroke involving face, arm, and leg. Neurology 1965, 15: 76–80.PubMedCrossRefGoogle Scholar
  43. 43.
    Fisher CM: Pure sensory stroke and allied conditions. Stroke 1982, 13: 434–447.PubMedCrossRefGoogle Scholar
  44. 44.
    Orgogozo JM, Bogousslaysky J: Lacunar Syndromes. In Handbook of Clinical Neurology. Edited by Toole JF. New York: Elsevier Science Publishers; 1989: 235–269.Google Scholar
  45. 45.
    Besson G, Hommel M: Lacunar Syndrome. In Advances in Neurology. vol 62. Cerebral Small Artery Disease. Edited by Pullicino PM, Caplan LR, Hommel M. New York: Raven Press; 1993: 141–159.Google Scholar
  46. 46.
    Ropper AH, Fisher CM, Kleinman GM: Pyramidal infarction in the medulla: a cause of pure motor hemiplegia sparing face. Neurology 1979, 29: 91–95.PubMedCrossRefGoogle Scholar
  47. 47.
    Fisher CM, Cole M: Homolateral ataxia with crural paresis: a vascular syndrome. J Neurol Neurosurg Psychiatry 1965, 28: 48–55.PubMedCrossRefGoogle Scholar
  48. 48.
    Fisher CM: A lacunar syndrome: the dysarthria-clumsy hand syndrome. Neurology 1967, 17: 614–617.PubMedCrossRefGoogle Scholar
  49. 49.
    Fisher CM: Ataxic hemiparesis: a pathologic study. Arch Neurol 1978, 35: 126–128.PubMedCrossRefGoogle Scholar
  50. 50.
    Mohr JP, Kase CS, Meckler RJ, et al.: Sensorimotor stroke due to thalamocapsular ischemia. Arch Neurol 1977, 34:739–741.Google Scholar
  51. 51.
    Marie P: Des foyers lacunaire de desintegration et de differents aytres etats cavitaires du cerveau. Rev Med 1901, 21: 281.Google Scholar
  52. 52.
    Mori E., Yoneda Y: Early Spontaneous Recanalization of Thromboembolic Stroke. In Thrombolytic Therapy in Acute Ischemic Stroke, vol 2. Edited by del Zoppo GJ, Mori E, Hacke. Berlin: Springer-Verlag, 1993: 129–137.CrossRefGoogle Scholar
  53. 53.
    Bladin PF: A radiologie and pathologic study of embolism of the internal carotid-middle cerebral arterial axis. Radiology 1964, 82: 615–625.PubMedGoogle Scholar
  54. 54.
    Irino T, Yaneda M, Takaku M: Angiographie manifestations in postrecanalized cerebral infarction. Neurology 1977, 27: 471–475.PubMedCrossRefGoogle Scholar
  55. 55.
    Kistler JP, Ropper AH, Martin JB: Cerebrovascular Diseases. In Harrison’s Principles of Internal Medicine edn 13. Edited by Isselbacher KJ, Martin JB, Braunwald E, et al.: New York: McGraw-Hill; 1994:2233–2256.Google Scholar
  56. 56.
    Kistler JP, Ropper AH, Heros RC: Therapy of ischemic cerebral vascular disease due to atherothrombosis. N Engl J Med 1984,311: 27–34, 100–105.Google Scholar
  57. 57.
    Sacco RL, Ellenberg JH, Mohr JP, et al.: Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989, 25:382–390.Google Scholar
  58. 58.
    Melo TP, Bogousslaysky J, Van Melle G, et al.: Pure motor stroke: a reappraisal. Neurology 1992, 42:789–798.Google Scholar
  59. 59.
    Adams RD, Victor M: Cerebrovascular Diseases. In Principles of Neurology. Edited by Adams RD, Victor M. New York: McGraw-Hill; 1993: 669–748.Google Scholar
  60. 60.
    Helgason CM: Anterior Choroidal Artery. In Stroke Syndromes. Edited by Bogousslaysky J, Caplan L. New York: Cambridge University Press; 1995: 270–275.Google Scholar
  61. 61.
    Mohr JP, Steinke W, Timsit SG, et al.: The anterior choroidal artery does not supply the corona radiata and the lateral ventricular wall. Stroke 1991, 22:1502–1507.Google Scholar
  62. 62.
    Mohr JP, Gautier JC, Pessin MS: Internal Carotid Artery Disease. In Stroke: Pathophysiology, Diagnosis and Management edn 2. Edited by Barnett HJM, Bennett MS, Mohr JP, et al.: New York: Churchill Livingstone; 1992:285–335.Google Scholar
  63. 63.
    Kistler JP: Cerebral embolism. Compr Ther 1996, 22 (8): 515–530.PubMedGoogle Scholar
  64. 64.
    Orsinelli DA, Pearson AC: Detection of prosthetic valve strands by trans-esophageal echocardiography: clinical significance in patients with suspected cardiac source of embolism. J Am Coll Cardiol 1995, 26: 1713–1718.PubMedCrossRefGoogle Scholar
  65. 65.
    Hacke W: Thrombolysis: Stroke Subtypes and Embolus Type. In Thrombolytic Therapy in Acute Ischemic Stroke II. Edited by del Zoppo GJ, Mori E, Hacke W. Berlin: Springer-Verlag; 1993: 153–159.CrossRefGoogle Scholar
  66. 66.
    Barnett HJM, Jones MW, Boughner DR, et al.: Cerebral ischemic events associated with prolapsing mitral valve. Arch Neurol 1976, 33:777–782.Google Scholar
  67. 67.
    Gilon D, Buonanno FS, Kistler JP, et al.: Mitral valve prolapse: Is it associated with acute ischemic neurologic events? Circulation 1995, 92(suppl I):1–284.Google Scholar
  68. 68.
    Marks AR, Choong CY, Chir MB, et al.: Identification of high-risk and low-risk subgroups of patients with mitral valve prolapse. N Engl J Med 1989, 320:1031–1036.Google Scholar
  69. 69.
    Nishimura RA, McGoon MD, Shu C, et al.: Echocardiographically documented mitral valve prolapse: long-term follow-up of 237 patients. N Engl J Med 1985, 313:1305–1309.Google Scholar
  70. 70.
    Finkelhor RS, Lamont WE, Ramanavarapu SK, et al.: Spontaneous echocardiographic contrast in the thoracic aorta: factors associated with its occurrence and its association with embolic events. Am Heart J 1995,130:1254–1258.Google Scholar
  71. 71.
    Mikell FL, Asinger RW, Elsperger KJ, et al.: Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombus. Circulation 1982, 66:755–763.Google Scholar
  72. 72.
    Mahony C, Spain C, Spain M, et al.: Spontaneous contrast and intravascular platelet aggregation. J. Ultrasound Med 1994, 13:443–450.Google Scholar
  73. 73.
    Chimowitz MI, DeGeorgia MA, Poole M, et al.: Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke 1993, 24:1015–1019.Google Scholar
  74. 74.
    Mounier-Vehier F, Leys D, Rondepierre PH, et al.: Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium. Stroke 1993, 24:1347–1351.Google Scholar
  75. 75.
    Jones HR Jr, Caplan LR, Come PC, et al.: Cerebral emboli of paradoxical origin. Ann Neurol 1983, 13:314–319.Google Scholar
  76. 76.
    Lechat PH, Mas JL, Lascault G, et al.: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988, 318:1148–1152.Google Scholar
  77. 77.
    DiTullio MR, Sacco RL, Venketasubramanian N, et al.: Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993, 24:1020–1024.Google Scholar
  78. 78.
    Homma S, DiTullio MR, Sacco RL, et al.: Characteristics of patent foramen ovale associated with cryptogenic stroke: a biplane transesophageal echocardiographic study. Stroke 1994, 25:582–586.Google Scholar
  79. 79.
    DiTullio MR, Sacco RL, Gopal A, et al.: Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992, 117:461–465.Google Scholar
  80. 80.
    Hanna JP, Sun JP, Furlan AJ, et al.: Patent foramen ovale and brain infarct: echocardiographic predictors, recurrence and prevention. Stroke 1994, 25:782–786.Google Scholar
  81. 81.
    Cabanes L, Mas JL, Cohen A, et al.: Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age: a study using transesophageal echocardiography. Stroke 1993, 24:1865–1873.Google Scholar
  82. 82.
    Kistler JP, Furie KL: Patent foramen ovale diameter and embolic stroke: a part of the puzzle? Am J Med 2000, 109: 506–507.PubMedCrossRefGoogle Scholar
  83. 83.
    Ranoux D, Cohen A, Cabanes L, et al.: Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993, 24:31–34.Google Scholar
  84. 84.
    Bridges ND, Hellenbrand W, Latson L, et al.: Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992, 86:1902–1908.Google Scholar
  85. 85.
    Rome JJ, Keane JF, Perry SB, et al.: Double-umbrella closure of atrial defects: initial clinical applications. Circulation 1990, 82:751–758.Google Scholar
  86. 86.
    Falk RH: A plea for a clinical trial of anticoagulation in dilated cardiomyopathy. Am J Cardiol 1990, 65: 914–915.PubMedCrossRefGoogle Scholar
  87. 87.
    Fuster V, Gersh BJ, Giuliani ER, et al.: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981, 47:525–530.Google Scholar
  88. 88.
    Roberts WC, Siegel RJ, McManus BM: Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987, 60: 1340–1355.PubMedCrossRefGoogle Scholar
  89. 89.
    Cheng JWM, Spinier SA: Should all patients with dilated cardiomyopathy receive chronic anticoagulation? Ann Pharmacother 1994, 28: 604–609.PubMedGoogle Scholar
  90. 90.
    Laupacis A, Albers G, Dunn M, et al.: Antithrombotic therapy in atrial fibrillation. Chest 1992,102(suppl 4):S426–S433.Google Scholar
  91. 91.
    Lopez JA, Ross RS, Fishbein MC, et al.: Nonbacterial thrombotic endocarditis: a review. Am Heart J 1987, 113:773–784.Google Scholar
  92. 92.
    Biller J, Chalk VR, Toole JF, et al.: Nonbacterial thrombotic endocarditis a neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol 1982, 39:95–98.Google Scholar
  93. 93.
    Kooiker JC, MacLean JM, Sumi SM: Cerebral embolism, marantic endocarditis, and cancer. Arch Neurol 1976, 33: 260–264.PubMedCrossRefGoogle Scholar
  94. 94.
    Lehto VP, Stenman S, Somer T: Immunohistochemical studies on valvular vegetations in nonbacterial thrombotic endocarditis (NBTE). Acta Pathol Microbial Immunol Scand (A) 1982, 90: 207–211.Google Scholar
  95. 95.
    Meltzer RS, Visser CA, Fuster V: Intracardiac thrombi and systemic embolization. Ann Intern Med 1986, 104: 689–698.PubMedCrossRefGoogle Scholar
  96. 96.
    Chesebro JL, Fuster V: Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism. Circulation 1986, 74 (suppl III): 1–10.CrossRefGoogle Scholar
  97. 97.
    Halperin JL, Fuster V: Left ventricular thrombus and stroke after myocardial infarction: toward prevention or perplexity? J Am Coll Cardiol 1989, 14: 912–914.PubMedCrossRefGoogle Scholar
  98. 98.
    Smith P, Arnesen H, Holme I: The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990, 323: 147–152.PubMedCrossRefGoogle Scholar
  99. 99.
    Kupper AJF, Verheugt FWA, Peels CH, et al.: Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation. J Am Coll Cardiol 1989, 13:1514–1520.Google Scholar
  100. 100.
    Tramarin R, Pozzoli M, Febo O, et al.: Two-dimensional echocardiographic assessment of anticoagulant therapy in left ventricular thrombosis early after acute myocardial infarction. Eur Heart J 1986, 7:482–492.Google Scholar
  101. 101.
    Cregler LL: Antithrombotic therapy in left ventricular thrombosis and systemic embolism. Am Heart J 1992,123:1110–1114.Google Scholar
  102. 102.
    Hess DC, D’Cruz IA, Adams RJ, et al.: Coronary Artery Disease, Myocardial Infarction, and Brain Embolism. In Neurologic Clinics: Neurocardiology,vol 11. Edited by Brillman J. Philadelphia: WB Saunders; 1993:399–417.Google Scholar
  103. 103.
    Case Records of the Massachussetts General Hospital weekly clinico-pathological exercises. Case 451970. N Engl J Med 1970, 283: 982–990.Google Scholar
  104. 104.
    Fourth ACCP Consensus Conference on Antithrombotic Therapy. Edited by Dalen JE, Hirsh J. Chest 1995, 108(suppl 4 ): 225S - 522S.Google Scholar
  105. 105.
    Szekely P: Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Med J 1964, 1: 1209–1212.PubMedCrossRefGoogle Scholar
  106. 106.
    Becker RC, Ansell J: Antithrombotic therapy: an abbreviated reference for clinicians. Arch Intern Med 1995, 155: 149–161.PubMedCrossRefGoogle Scholar
  107. 107.
    Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med 1987, 147: 1561–1564.PubMedCrossRefGoogle Scholar
  108. 108.
    Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991, 22: 983–988.PubMedCrossRefGoogle Scholar
  109. 109.
    Petersen P Godtfredsen J, Boysen G, et al.: Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989, 1:175–179.Google Scholar
  110. 110.
    Stroke Prevention in Atrial Fibrillation Investigators: stroke prevention in atrial fibrillation study: final results. Circulation 1991, 89:527–539.Google Scholar
  111. 111.
    Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990, 323: 1505–1511.Google Scholar
  112. 112.
    CAFA Study Investigators: Canadian atrial fibrillation (CAFA) study. J Am Coll Cardiol 1991, 18: 349–355.CrossRefGoogle Scholar
  113. 113.
    Ezekowitz MD, Bridgers SL, James KE, et al.: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992, 327:1406–1412.Google Scholar
  114. 114.
    Laupacis A, Boysen G, Connolly S, et al.: Atrial fibrillation: risk factors for embolization and efficacy of anti-thrombotic therapy. Arch Intern Med 1994, 154:1449–1457.Google Scholar
  115. 115.
    Turpie AGG, Gunstensen J, Hirsh J, et al.: Randomized comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet 1988, 1:1242–1245.Google Scholar
  116. 116.
    Fourth ACCP Consensus Conference on Antithrombotic Therapy. Edited by Dalen JE, Hirsh J. Chest 1995,108(suppl 4 ): 225S - 522S.Google Scholar
  117. 117.
    Becker RC, Ansell J: Antithrombotic therapy: an abbreviated reference for clinicians. Arch Intern Med 1995, 155: 149–161.PubMedCrossRefGoogle Scholar
  118. 118.
    Kistler JP, Singer DA, Millenson MM, et al.: for the BAATAF investigators: Effect of low intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. Stroke 1993, 24:1360–1365.Google Scholar
  119. 119.
    Rosenberg RD, Aird WC: Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999, 340: 1555–1564.PubMedCrossRefGoogle Scholar
  120. 120.
    Kistler JP, Bauer KA: The Level of Activity of the Hemostatic System, the Rate of Embolic Stroke, and Age: Is There a Correlation? In Cerebrovascular Diseases. Edited by Moskowitz MA, Caplan LR. Boston: Butterworth-Heinemann; 1995: 437–442.Google Scholar
  121. 121.
    Pruitt AA, Rubin RH, Karchmer AW, et al.: Neurologic complications of bacterial endocarditis. Medicine (Baltimore) 1978, 57:329–343.Google Scholar
  122. 122.
    Salgado AV, Furlan AJ, Keys TF, et al.: Neurologic complications of endocarditis: a 12-year experience. Neurology 1989, 39:173–178.Google Scholar
  123. 123.
    Francioli P: Central Nervous System Complications of Infective Endocarditis. In Infections of the Central Nervous System. Edited by Scheld WM, Whitley RJ, Durack DJ. New York: Raven Press; 1991: 515–559.Google Scholar
  124. 124.
    Roeltgen DP, Syna DR: Neurologic Complications of Cardiac Tumors. In Handbook of Clinical Neurology, vol 19. Edited by Goetz CG, Tanner CM, AminoffMJ. Amsterdam: Elsevier Science Publishers; 1993: 93–109.Google Scholar
  125. 125.
    Peters MN, Hall RJ, Cooley DA, et al.: The clinical syndrome of atrial myxoma. JAMA 1974, 230:695–700.Google Scholar
  126. 126.
    Wold LE, Lie JT: Atrial myxomas: a clinicopathological profile. Am J Pathol 1980, 101: 219–240.PubMedGoogle Scholar
  127. 127.
    Thompson J, Kapoor W, Wechsler LR: Multiple strokes due to atrial myxoma with a negative echocardiogram. Stroke 1988, 19: 1570–1571.PubMedCrossRefGoogle Scholar
  128. 128.
    Knepper LE, Biller J, Adams HP Jr, Bruno A: Neurologic manifestations of atrial myxoma: a 12 year experience and review. Stroke 1988, 19: 1435–1440.PubMedCrossRefGoogle Scholar
  129. 129.
    Reynen K: Cardiac myxomas. N Engl J Med 1995, 333: 1610–1617.PubMedCrossRefGoogle Scholar
  130. 130.
    Amarenco P, Cohen A, Baudrimont M, et al.: Transesophageal echocardiographic detection of aortic arch disease in patients with cerebral infarction. Stroke 1992, 23:1005–1009.Google Scholar
  131. 131.
    Amarenco P, Duyckaerts C, Tzourio C, et al.: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992, 326:221–225.Google Scholar
  132. 132.
    Amarenco P, Cohen A, Tzourio C, et al.: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994, 331:1474–1479.Google Scholar
  133. 133.
    Khatibzadeh M, Mitusch R, Stierle U, et al.: Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996, 27:664–669.Google Scholar
  134. 134.
    Kistler JP: The risk of embolic stroke another piece of the puzzle. N Engl J Med 1994, 331: 1517–1519.PubMedCrossRefGoogle Scholar
  135. 135.
    French Study of Aortic Plaques in Stroke Group: Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996, 334: 1216–1221.Google Scholar
  136. 136.
    Moore PM, Cupps TR: Neurological complications of vasculitis. Ann Neural 1983, 14: 155–167.CrossRefGoogle Scholar
  137. 137.
    Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis. Ann Intern Med 1978, 89: 660–676.PubMedCrossRefGoogle Scholar
  138. 138.
    Kurent JE, Moore PM: Vasculitis of the Nervous System. In Systemic Vasculitis, the Biological Basis. Edited by LeRoy EC. New York: Marcel Dekker; 1992: 451–482.Google Scholar
  139. 139.
    Biller J, Sparks LH: Diagnosis and Management of Cerebral Vasculitis. In Handbook of Cerebrovascular Diseases. Edited by Adams HP. New York: Marcel Dekker; 1993: 549–568.Google Scholar
  140. 140.
    Giang D: Central nervous system vasculitis secondary to infections, toxins, and neoplasms. Semin Neurol 1994, 14: 313–319.PubMedCrossRefGoogle Scholar
  141. 141.
    Suwanwela C, Suwanwela N, Charuchinda S, et al.: Intracranial mycotic aneurysm of extravascular origin. J Neurosurg 1972, 36:552–559.Google Scholar
  142. 142.
    Reshef E, Greenberg SE, Jancovic J: Herpes zoster ophthalmicus followed by contralateral hemiparesis: report of two cases and review of literature. J Neurol Neurosurg Psychiatry 1985, 48: 122–127.PubMedCrossRefGoogle Scholar
  143. 143.
    Brown MM, Swash M: Polyarteritis Nodosa and Other Systemic Vasculitides. In Handbook of Clinical Neurology, vol 11, no. 5. Edited by Toole JF. Amsterdam. Elsevier Science Publishers; 1989: 353–367.Google Scholar
  144. 144.
    Kissel JT: Neurologic manifestations of vasculitis. Neural Clin 1989, 7: 655–673.Google Scholar
  145. 145.
    Ferris EJ, Levine HL: Cerebral arteritis. Radiology 1972, 109: 327–341.Google Scholar
  146. 146.
    Moore PM, Calabrese LH: Neurologic manifestations of systemic vasculitides. Semin Neurol 1994, 14: 300–306.PubMedCrossRefGoogle Scholar
  147. 147.
    Jennette JC, Falk RJ, Milling DM: Pathogenesis of vasculitis. Semin Neurol 1994, 14: 291–299.PubMedCrossRefGoogle Scholar
  148. 148.
    Tunkel AR, Scheld WM: Bacterial meningitis: Pathogenic and Pathophysiologic Mechanisms. In Infections of the Central Nervous System. Edited by Lambert HP. Philadelphia: BC Decker; 1991: 1–15.Google Scholar
  149. 149.
    Igarashi M, Gilmartin RC, Gerald B, et al.: Cerebral arteritis and bacterial meningitis. Arch Neural 1984, 41:531–535.Google Scholar
  150. 150.
    Simon RP: Neurosyphilis. Arch Neurol 1985, 42: 606–613.PubMedCrossRefGoogle Scholar
  151. 151.
    Case record of Massachusetts General Hospital. N Engl J Med 1991, 325: 414–422.Google Scholar
  152. 152.
    Teoh R, Humphries M: Tuberculous Meningitis. In Infections of the Central Nervous System. Edited by Lambert HP. Philadelphia: BC Decker; 1991: 189–206.Google Scholar
  153. 153.
    Hsieh E, Chia L, Shen W: Location of cerebral infarctions in tuberculous meningitis. Neuroradiology 1992, 34: 197–199.PubMedCrossRefGoogle Scholar
  154. 154.
    Saravia-Gomez J: Aspergillosis of the Central Nervous System. In Handbook of Clinical Neurology. Part III. Infection of the Nervous System. Edited by Vinken PJ, Bruyn GW. Amsterdam: North-Holland; 1978: 531–539.Google Scholar
  155. 155.
    Walsh TJ, Hier DB, Caplan LR: Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985, 18: 574–582.PubMedCrossRefGoogle Scholar
  156. 156.
    Cook GC: Protozoan and Helminthic Infections. In Infections of the Central Nervous System. Edited by Kass EH, Weller TH, Wolff SM, et al.:. Philadelphia: BC Decker; 1991: 264–282.Google Scholar
  157. 157.
    Del Brutto OH, Sotelo J: Neurocysticercosis: an update. Rev Infectious Dis 1988, 10: 1075–1087.CrossRefGoogle Scholar
  158. 158.
    Suwanwela N, Piyachon C: Takayasu arteritis in Thailand: clinical and imaging features. Int J Cardiol (in press).Google Scholar
  159. 159.
    Matsubara O, Yoshimura N, Tamura A, et al.: Heart Vessels 1992, 7(suppl):18–25.Google Scholar
  160. 160.
    Caselli RHJ, Hunder GG, Whisnant JP: Neurologic disease in biopsy-proven giant cell arteritis. Neurology 1988, 38: 352–359.PubMedCrossRefGoogle Scholar
  161. 161.
    Hunder GG, Lie JT, Goronzy JJ, et al.: Pathogenesis of giant cell arteritis. Arthritis Rheum 1993, 36:757–761.Google Scholar
  162. 162.
    Turnbull J: Temporal arteritis and polymyalgia rheumatica: nosographic and nosologic considerations. Neurology 1996, 46: 901–906.PubMedCrossRefGoogle Scholar
  163. 163.
    Kansa T, Corbett JJ, Savino P, et al.: Giant cell arteritis with normal sedimentation rate. Arch Neurol 1977, 34:624–625.Google Scholar
  164. 164.
    Procter CD, Hollier LH, Trosclair CM: Temporal arteritis, clinical implications for the vascular surgeon. J Cardiovasc Surg 1992, 33: 599–603.Google Scholar
  165. 165.
    Case record of Massachusetts General Hospital. N Engl J Med 1986, 315: 631–639.Google Scholar
  166. 166.
    Vollmer TL, Guanaccia J, Harrington W, et al.: Idiopathic granulomatous angiitis of the central nervous system: diagnostic challenges. Arch Neural 1993,50:925–930.Google Scholar
  167. 167.
    Alhalabi M, Moore PM: Serial angiography in isolated angiitis of the central nervous system. Neurology 1994, 44: 1221–1226.PubMedCrossRefGoogle Scholar
  168. 168.
    Hurst RW, Grossman RI: Neuroradiology of central nervous system vasculitis. Semin Neurol 1994, 14: 320–340.PubMedCrossRefGoogle Scholar
  169. 169.
    Case record of Massachusetts General Hospital. N Engl J Med 1989, 320: 514–524.Google Scholar
  170. 170.
    Brown E, Prager J, Lee H, et al.: CNS complications of cocaine abuse: prevalence, pathophysiology and neuroradiology. AJR 1992,159:137–147.Google Scholar
  171. 171.
    Daras M, Tuchman AJ, Koppel BS, et al.: Neurovascular complications of cocaine. Acta Neural Scand 1994, 90:124–129.Google Scholar
  172. 172.
    Sturzenegger M, Huber P: Cranial nerve palsies in spontaneous carotid artery dissection. J Neurol Neurosurg Psychiatry 1993, 56 (11): 1191–1199.PubMedCrossRefGoogle Scholar
  173. 173.
    Mas J-L, Henin D, Bousser MG, et al.: Dissecting aneurysm of the vertebral artery and cervical manipulation: a case report with autopsy. Neurology 1989, 39:512–515.Google Scholar
  174. 174.
    Fisher CM: The headache and pain of spontaneous carotid dissection. Headache 1982, 22 (2): 60–65.PubMedCrossRefGoogle Scholar
  175. 175.
    Selky AK, Pascuzzi R: Reader’s paratrigeminal syndrome due to spontaneous dissection of the cervical and petrous internal carotid artery. Headache 1995, 35 (7): 423–424.CrossRefGoogle Scholar
  176. 176.
    Mokri B, Sundt TM, Houser OW, et al.: Spontaneous dissection of the cervical internal carotid artery. Ann Neurol 1986, 19:126–138.Google Scholar
  177. 177.
    Sturzenegger M, Mattle HP, Rivoir A, et al.: Ultrasound findings in carotid artery dissection: analysis of 43 patients. Neurology 1995, 45(4):691–698.Google Scholar
  178. 178.
    Nguyen Bui L, Brant-Zawadzki M, Verghese P, et al.: Magnetic resonance angiography of cervicocranial dissection. Stroke 1993,24(10):126–131.Google Scholar
  179. 179.
    Frisoni GB, Anzola GP: Vertebrobasilar ischemia after neck motion. Stroke 1991, 22: 1452–1460.PubMedCrossRefGoogle Scholar
  180. 180.
    Frumkin LR, Baloh RW: Wallenberg’s syndrome following neck manipulation. Neurology 1990, 40: 1990: 611–615.CrossRefGoogle Scholar
  181. 181.
    Sherman DG, Hart RG, Easton JD: Abrupt change in head position and cerebral infarction. Stroke 1981, 12: 2–6.PubMedCrossRefGoogle Scholar
  182. 182.
    Saver JL, Easton JD, Hart RG: Dissections and Trauma of Cervicocerebral Arteries. In Stroke: Pathophysiology, Diagnosis and Management, edn 2. Edited by Barnett HJM, Bennett MS, Mohr JP, et al.:. New York: Churchill Livingstone; 1992: 671–688.Google Scholar
  183. 183.
    Caplan LR, Baquis GD, Pessin MS, et al.: Dissection of the intracranial vertebral artery. Neurology 1988, 38:868–877.Google Scholar
  184. 184.
    Barnett HJM: Progress towards stroke prevention. Robert Wartenberg Lecture. Neurology 1980, 30: 1212–1225.PubMedCrossRefGoogle Scholar
  185. 185.
    Hinse P, Thie A, Lachenmayer L: Dissection of the extracranial vertebral artery: Report of four cases and review of the literature. J Neurol Neurosurg Psychiatry 1991, 54: 863–869.PubMedCrossRefGoogle Scholar
  186. 186.
    Adams HP, Kappelle LJ, Biller J, et al.: Ischemic stroke in young adults. Arch Neurol 1995, 52:491–495.Google Scholar
  187. 187.
    Bovill EG, Bauer KA, Dickerman JD, et al.: The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989, 73:712–717.Google Scholar
  188. 188.
    Miletich J, Sherman L, Broze G: Absence of thrombosis in patients with heterozygous protein C deficiency. N Engl J Med 1987, 317: 991–996.PubMedCrossRefGoogle Scholar
  189. 189.
    Bauer KA, Broekmans AW, Bertina RM, et al.: Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood 1988, 71:1418–1426.Google Scholar
  190. 190.
    Kosik KS, Furie B: Thrombotic stroke associated with elevated plasma factor VIII. Ann Neurol 1980, 8: 435–437.PubMedCrossRefGoogle Scholar
  191. 191.
    Brott T, Stump D: Overview of hemostasis and thrombosis. Semin Neurol 1991, 11: 305–313.PubMedCrossRefGoogle Scholar
  192. 192.
    Pavlakis SG, Bello J, Prohovnik I, et al.: Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol 1988, 23: 125–130.PubMedCrossRefGoogle Scholar
  193. 193.
    Rothman SM, Fulling KH, Nelson JS: Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neural 1986, 20: 684–690.CrossRefGoogle Scholar
  194. 194.
    Levine SR, Brey RL: Antiphospholipid antibodies and ischemic cerebrovascular disease. Semin Neurol 1991, 11: 329–338.PubMedCrossRefGoogle Scholar
  195. 195.
    Graus F, Rogers LR, Posner JB: Cerebrovascular complications in patients with cancer. Medicine 1985, 64: 16–35.PubMedCrossRefGoogle Scholar
  196. 196.
    Chaturvedi S, Ansell J, Recht L: Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 1994, 25: 1215–1218.PubMedCrossRefGoogle Scholar
  197. 197.
    Sun NC, McAfee WM, Hum GJ, et al.: Hemostatic abnormalities in malignancy: a prospective study of one hundred eight patients. Am J Clin Pathol 1979, 71:10–16.Google Scholar
  198. 198.
    Rickles FR, Edwards RL: Activation of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth. Cancer 1983, 51: 301–307.PubMedCrossRefGoogle Scholar
  199. 199.
    Mandel H, Brenner B, Berant M, et al.: Coexistence of hereditary homocystinuria and factor V Leiden: effect on thrombosis. N Engl J Med 1996, 334:763–768.Google Scholar
  200. 200.
    Hacke W, Zeumer H, Ferbert A, et al.: Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988, 19:1216–1222.Google Scholar
  201. 201.
    National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333: 1581–1587.Google Scholar
  202. 202.
    Thomas DJ, du Boulay GH, Marshall J, et al.: Effect of haematocrit on cerebral blood flow in men. Lancet 1977, 2:941–943.Google Scholar
  203. 203.
    Kay R, Wong KS, Yu YL, et al.: Low molecular weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995, 333:1588–1593.Google Scholar
  204. 204.
    European Cooperative Acute Stroke Study: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995, 274: 1017–1025.Google Scholar
  205. 205.
    del Zoppo GJ, Poeck K, Pessin MS, et al.: Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neural 1992, 32:78–86.Google Scholar
  206. 206.
    Stallones RA, Dyken ML, Fang HCH, et al.: Epidemiology for stroke facilities planning. Stroke 1972, 3:360–371.Google Scholar
  207. 207.
    Jeffery DR, Good DC: Rehabilitation of the stroke patient. Curr Opin Neural 1995, 8: 62–68.CrossRefGoogle Scholar
  208. 208.
    Duncan PW, Goldstein LB, Matchar D, et al.: Measurement of motor recovery after stroke. Stroke 1992, 23:1084–1089.Google Scholar
  209. 209.
    Nakayama H, Jorgensen HS, Raaschou HO, et al.: Recovery of upper extremity function in stroke patients: the Copenhagen stroke study. Arch Phys Med Rehabil 1994, 75:394–398.Google Scholar
  210. 210.
    Twitchell TE: Restoration of motor function following hemiplegia in man. Brain 1951, 74: 443–480.PubMedCrossRefGoogle Scholar
  211. 211.
    Weiller C, Ramsay SC, Wise RJS, et al.: Individual patterns of functional reorganization in the human cerebral cortex after capsular infarction. Ann Neural 1993, 33:181–189.Google Scholar
  212. 212.
    Jones TA, Schallert T: Use-dependent growth of pyramidal neurons after neo-cortical damage. J Neurosci 1994, 14: 2140–2152.PubMedGoogle Scholar
  213. 213.
    Feeney DM, Gonzalez A, Law WA: Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982, 217: 855–857.PubMedCrossRefGoogle Scholar
  214. 214.
    Goldstein LB: Common drugs may influence motor recovery after stroke: The Sygen In Acute Stroke Study Investigators. Neurology 1995, 45: 865–871.PubMedCrossRefGoogle Scholar
  215. 215.
    Crisostomo EA, Duncan PW, Propst M, et al.: Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neural 1988, 23:94–97.Google Scholar
  216. 216.
    Walker-Batson D, Smith P, Curtis S, et al.: Amphetamine paired with physical therapy accelerates motor recovery after stroke. Stroke 1995, 26:2254–2259.Google Scholar
  217. 217.
    Ojeman R, Mohr J: Hypertensive brain hemorrhage. Clin Neurosurg 1975, 23: 220.Google Scholar
  218. 218.
    Mohr J, Caplan L, Melski J, et al.: The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978, 28:754–762.Google Scholar
  219. 219.
    Fisher C: Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 1971, 30: 536–550.PubMedCrossRefGoogle Scholar
  220. 220.
    Freytag E: Fatal hypertensive intracerebral hematomas: a survey of the pathological anatomy in 393 cases. J Neurol Neurosurg Psychiatry 1968, 31: 616–620.CrossRefGoogle Scholar
  221. 221.
    Ojeman R, Mohr J: Hypertensive brain hemorrhage. Clin Neurosurg 1975, 23: 220–244.Google Scholar
  222. 222.
    Ojeman R, Heros R: Spontaneous brain hemorrhage. Stroke 1983, 14: 468–475.CrossRefGoogle Scholar
  223. 223.
    Fisher C, Picard E, Polak A, et al.: Acute hypertensive cerebellar hemorrhage: diagnosis and surgical treatment. J Nery Ment Dis 1965, 140:38–45.Google Scholar
  224. 224.
    Kase CS: Cerebral Amyloid Angiopathy. In Intracerebral Hemorrhage. Edited by Kase CS, Caplan LR. Boston: Butterworth-Heinemann; 1994: 179–200.Google Scholar
  225. 225.
    Vinters HV: Cerebral amyloid angiopathy: a critical review. Stroke 1987, 18: 311–324.PubMedCrossRefGoogle Scholar
  226. 226.
    Yankner BA, Dawes LR, Fisher S, et al.: Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science 1989, 245:417–420.Google Scholar
  227. 227.
    Mandybur TI: Cerebral amyloid angiopathy: the vascular pathology and complications. JNeuropathol Exp Neurol 1986, 45: 79–90.CrossRefGoogle Scholar
  228. 228.
    Vonsattel JP, Myers RH, Hedley-Whyte ET, et al.: Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991, 30:637–649.Google Scholar
  229. 229.
    Maeda A, Yamada M, Itoh Y, et al.: Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy. Stroke 1993, 24:1857–1864.Google Scholar
  230. 230.
    Roher AE, Lowenson JD, Clarke S, et al.: 3-Amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 1993, 90:10836–10840.Google Scholar
  231. 231.
    Gravina SA, Ho LB, Eckman CB, et al.: Amyloid 3 protein (a-ß) in Alzheimer’s disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at a-ß-40 or a-(3–42(43). J Biol Chem 1995, 270:7013–7016.Google Scholar
  232. 232.
    Suzuki N, Cheung TT, Cai XD, et al.: An increased percentage of long amyloid 13 protein secreted by familial amyloid ß protein precursor (3 APP717) mutants. Science 1994, 264:1336–1340.Google Scholar
  233. 233.
    Greene GM, Godersky JC, Biller J, et al.: Surgical experience with cerebral amyloid angiopathy. Stroke 1990, 21:1545–1549.Google Scholar
  234. 234.
    Matkovic Z, Davis S, Gonzales M, et al.: Surgical risk of hemorrhage in cerebral amyloid angiopathy. Stroke 1991, 22:456–461.Google Scholar
  235. 235.
    Izumihara A, Ishihara T, Iwamoto N, Ito H: Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Stroke 1999, 30: 29–33.PubMedCrossRefGoogle Scholar
  236. 236.
    Greenberg SM, Vonsattel JP: Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 1997, 28: 1418–1422.PubMedCrossRefGoogle Scholar
  237. 237.
    Rosand J, Hylek EM, O’Donnell HC, Greenberg SM: Warfarin-associated hemorrhage and cerebral amyloid angiopathy. A genetic and pathological study. Neurology 2000, 55: 947–955.PubMedCrossRefGoogle Scholar
  238. 238.
    Knudsen KA, Rosand J, Karluk D, Greenberg SM: Clinical diagnosis of cerebral amyloid angiopathy. Validation of the Boston criteria [abstract]. Neurology 2000, 54: A467.Google Scholar
  239. 239.
    Greenberg SM, Finklestein SP, Schaefer PW: Petechial hemorrhages accompanying lobar hemorrhages: Detection by gradient-echo MRI. Neurology 1996, 46: 1751–1754.PubMedCrossRefGoogle Scholar
  240. 240.
    Caplan LR: Binswanger’s disease-revisited. Neurology 1995, 45: 626–633.PubMedCrossRefGoogle Scholar
  241. 241.
    Greenberg SM, Vonsattel JP, Stakes JW, et al.: The clinical spectrum of cerebral amyloid angiopathy: Presentations without lobar hemorrhage. Neurology 1993, 43:2073–2079.Google Scholar
  242. 242.
    Greenberg SM, Rebeck GW, Vonsattel JPV, et al.: Apolipoprotein E e4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995, 38:254–259.Google Scholar
  243. 243.
    Premkumar DR, Cohen DL, Hedera P, et al.: Apolipoprotein E-e4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease. Am J Pathol 1996, 148:2083–2095.Google Scholar
  244. 244.
    Nicoll JA, Burnett C, Love S, et al.: High frequency of apolipoprotein E €2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997, 41:716–721.Google Scholar
  245. 245.
    Greenberg SM, Vonsattel JP, Segal AZ, et al.: Association of apolipoprotein E €2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998, 50:961–965.Google Scholar
  246. 246.
    Levy E, Carman MD, Fernandez Madrid IJ, et al.: Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990, 248:1124–1126.Google Scholar
  247. 247.
    Van Broeckhoven C, Haan J, Bakker E, et al.: Amyloid 13 protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 1990, 248:1120–1122.Google Scholar
  248. 248.
    Hendriks L, van Duijn CM, Cras P, et al.: Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the P-amyloid precursor protein gene. Nat Genet 1992, 1:218–221.Google Scholar
  249. 249.
    Cho HS, Grabowski TJ, Rebeck GW, Greenberg SM: APP mutation at a novel site. The Iowa Mutation (D694N) associated with cognitive decline and severe cerebral amyloid angiopathy. Soc Neurosci Abs 2000, in press.Google Scholar
  250. 250.
    Palsdottir A, Abrahamson M, Thorsteinsson L, et al.: Mutation in cystatin C gene causes hereditary brain hemorrhage. Lancet 1988, 2:603–604.Google Scholar
  251. 251.
    Levy E, Lobez-Otin C, Ghiso J, et al.: Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 1989, 169:1771–1778.Google Scholar
  252. 252.
    Graffagnino C, Herbstreith MH, Roses AD, Alberts MJ: A molecular genetic study of intracerebral hemorrhage. Arch Neurol 1994, 51: 981–984.PubMedCrossRefGoogle Scholar
  253. 253.
    Anders KH, Wang ZZ, Kornfeld M, et al.: Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. Hum Pathol 1997, 28:1237–1246.Google Scholar
  254. 254.
    Itoh Y, Yamada M: Cerebral amyloid angiopathy in the elderly: the clinico-pathological features, pathogenesis, and risk factors. J Med Dent Sci 1997, 44: 11–19.PubMedGoogle Scholar
  255. 255.
    Nagai A, Kobayashi S, Shimode K, et al.: No mutations in cystatin C gene in cerebral amyloid angiopathy with cystatin C deposition. Mol Chem Neuropathol 1998, 33:63–78.Google Scholar
  256. 256.
    McCarron MO, Nicoll JA, Stewart J, et al.: Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy-related hemorrhage. Neurology 2000, 54:242–244.Google Scholar
  257. 257.
    O’Donnell HC, Rosand J, Knudsen KA, et al.:: Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000, 342: 240–245.CrossRefGoogle Scholar
  258. 258.
    Hunt W, Hess R: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968, 28: 14–20.PubMedCrossRefGoogle Scholar
  259. 259.
    Wirth F: Surgical Treatment of Incidental Intracranial Aneurysms. In Clinical Neurosurgery. Edited by Wirth E. Baltimore: Williams &Wilkins; 1985.Google Scholar
  260. 260.
    Garaway W, Whinant J, Drury I: The continuing decline in the incidence of stroke. Mayo Clin Proc 1983, 58: 520–523.Google Scholar
  261. 261.
    Weir B: Intracranial Aneurysms and Subarachnoid Hemorrhage. In Neurosurgery. Edited by Wilkins RH, Rengachray SS. New York: McGraw-Hill; 1985: 1308–1329.Google Scholar
  262. 262.
    Haley E, Kassell N, Torner J, et al.: Early versus delayed surgery for ruptured aneurysm [Abstract]. Stroke 1992, 23:30.Google Scholar
  263. 263.
    Adams HJ, Kassel N, Torner J, et al.: Early management of aneurysmal subarachnoid hemorrhage: a report from the Cooperative Aneurysm Study. J Neurosurg 1981, 54:141–145.Google Scholar
  264. 264.
    Bailes J, Spetzler R, Hadley M, et al.: Management morbidity and mortality of poor grade aneurysm patients. J Neurosurg 1990, 72:559–566.Google Scholar
  265. 265.
    Jane J, Kassell N, Torner J, et al.: The natural history of aneurysms and arteriovenous malformations. J Neurosurg 1985, 62:321–323.Google Scholar
  266. 266.
    Dell S: A symptomatic cerebral aneurysm: assessment of its risk of rupture. Neurosurgery 1982, 10: 162–166.PubMedCrossRefGoogle Scholar
  267. 267.
    Black P: Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysm. Neurosurgery 1986, 18: 12–16.PubMedCrossRefGoogle Scholar
  268. 268.
    Kusske J, Turner P, Ojemann G: Ventriculostomy for the treatment of acute hydrocephalus following subarachnoid hemorrhage. J Neurosurg 1973, 38: 591–595.PubMedCrossRefGoogle Scholar
  269. 269.
    Fisher C, Kistler J, Davis J: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980, 6: 1–9.PubMedCrossRefGoogle Scholar
  270. 270.
    Kaku Y, Yonekawa Y, Tsukabara T, et al.: Supraselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992, 77:847–848.Google Scholar
  271. 271.
    Marks M, Steinberg G, Lane B: Intraarterial papaverine for the treatment of vasospasm. Am J Neuroradiol 1993, 14: 822–826.PubMedGoogle Scholar
  272. 272.
    Newell D, Winn H: Transcranial Doppler in cerebral vasospasm. Neurosurg Clin North Am 1990, 1: 319–328.Google Scholar
  273. 273.
    Sundt T, Whisnant J: Subarachnoid hemorrhage from intracranial aneurysms. N Engl J Med 1978, 299: 116–122.PubMedCrossRefGoogle Scholar
  274. 274.
    Fisher C, Roberson G, Ojeman R: Cerebral vasospasm with ruptured saccular aneurysm: the clinical manifestations. Neurosurgery 1977, 1: 245–248.PubMedCrossRefGoogle Scholar
  275. 275.
    Awad I, Carter L, Spetzler R, et al.: Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987, 18:365–372.Google Scholar
  276. 276.
    Findlay J, Kassell N, Weir B, et al.: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995, 37:168–178.Google Scholar
  277. 277.
    Newell D, Eskridge J, Mayberg M, et al.: Angioplasty for treatment of symptomatic vasospasm. JNeurosurg 1989, 71:654–660.Google Scholar
  278. 278.
    Weir B: Epidemiology. In Aneurysms Affecting the Nervous System. Baltimore: Williams &Wilkins, 1987: 19–53.Google Scholar
  279. 279.
    Morley T, Barr H: Giant intracranial aneurysms diagnosis, course and management. Clin Neurosurg 1969, 16: 73–94.PubMedGoogle Scholar
  280. 280.
    Zabramski J, Spetzler R: Management of Mycotic Aneurysms. In Stroke. Edited by Barnett H, Mohr J, Stein B, et al.:. New York: Churchill Livingstone; 1992: 1065–1066.Google Scholar
  281. 281.
    Ondra S, Troupp H, George E, et al.: The natural history of symptomatic arteriovenous malformations. J Neurosurg 1990, 73:387–391.Google Scholar
  282. 282.
    Tsementzis S: Surgical management of intracerebral hematomas. Neurosurgery 1985, 16: 562–572.PubMedCrossRefGoogle Scholar
  283. 283.
    McCormick WF: The pathology of vascular (“arteriovenous”) malformations. J Neurosurg 1966, 24: 807–816.PubMedCrossRefGoogle Scholar
  284. 284.
    Curling OJ, Kelly DJ, Elster A, et al.: An analysis of the natural history of the cavernous angioma. Neurosurgery 1991, 75:702.Google Scholar
  285. 285.
    Robinson J, Award I, Little J: Natural history of cavernous angioma. J Neurosurg 1991, 75: 709–714.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Karen L. Furie
  • Christopher S. Ogilvy
  • Martin Smrčka
  • Nijasri C. Suwanwela
  • Ufuk Can
  • Hakan Ay
  • Steven C. Cramer
  • Steven M. Greenberg
  • Guy Rordorf
  • Seth P. Finklestein
  • Gary P. Foster
  • Walter J. Koroshetz
  • Nitaya Suwanwela
  • J. Philip Kistler

There are no affiliations available

Personalised recommendations